You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Local advanced

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gingival Recession Trial (Use of coronally advanced flap (CAF) and collagen matrix (CM), Use of coronally advanced flap (CAF)

Completed
  • Gingival Recession
  • Use of coronally advanced flap (CAF) and collagen matrix (CM)
  • Use of coronally advanced flap (CAF) and collagen matrix (CM) and additional application of enamel matrix derivatives (EMD).
  • (no location specified)
Mar 23, 2023

Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab, Camrelizumanb plus TPF)

Active, not recruiting
  • Oral Squamous Cell Carcinoma
  • Wuhan, Hubei, China
    Hospital of Stomatology, Wuhan University
Aug 17, 2022

Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)

Not yet recruiting
  • Advanced Solid Tumors
  • Madrid, M, Spain
  • +1 more
Dec 23, 2022

Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal

Recruiting
  • Rectal Cancer
  • +6 more
    • Wuhan, Hubei, China
    • +1 more
    Jul 12, 2022

    Colorectal Cancer, Adjuvant Chemo Trial in Guangzhou (wait and watch, adjuvant chemo)

    Recruiting
    • Colorectal Cancer
    • Adjuvant Chemotherapy
    • wait and watch
    • adjuvant chemotherapy
    • Guangzhou, Guangdong, China
      Sixth Affiliated Hospital of Sun Yat-sen University
    Jan 25, 2022

    Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in Beijing (RC48-ADC)

    Completed
    • Gastric Cancer
    • HER2 Overexpressing Gastric Carcinoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 12, 2022

    Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

    Not yet recruiting
    • Androgen Deprivation Therapy
    • Locally Advanced Prostate Cancer
    • Relugolix and Enzalutamide
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center at OU Health, University of Oklahoma He
    Nov 8, 2023

    Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

    Recruiting
    • Advanced Cancer
    • Relatlimab
    • +3 more
    • Duarte, California
    • +23 more
    Oct 24, 2022

    Stage III Esophageal Squamous Cell Carcinoma Trial in Shanghai (Paclitaxel and Cisplatin, Paclitaxel and Fluorouracil,

    Completed
    • Stage III Esophageal Squamous Cell Carcinoma
    • Paclitaxel and Cisplatin
    • +3 more
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Feb 8, 2022

    Advanced Solid Tumors Trial in Beijing (BMS-986213)

    Recruiting
    • Advanced Solid Tumors
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • TP53-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Stage IV
    • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
    • +2 more
    • Aarau, Switzerland
    • +7 more
    Oct 27, 2023

    Carcinoma, Hepatocellular Trial in Worldwide (Relatlimab, Nivolumab, Bevacizumab)

    Recruiting
    • Carcinoma, Hepatocellular
    • Los Angeles, California
    • +62 more
    Feb 1, 2023

    NSCLC Trial in Worldwide (Nivolumab)

    Completed
    Has Results
    • Non-Small Cell Lung Cancer
    • Nivolumab
    • Birmingham, Alabama
    • +16 more
    Dec 1, 2022

    Advanced Cancer Trial in Worldwide (BMS-986148, Nivolumab)

    Terminated
    Has Results
    • Advanced Cancer
    • La Jolla, California
    • +16 more
    Jul 21, 2022

    Head Neck Cancer Trial in Guangzhou (Jeksung combined with anti-radiation spray)

    Recruiting
    • Head and Neck Cancer
    • Jeksung combined with anti-radiation spray
    • Guangzhou, Guangdong, China
      Yu Zeng
    May 4, 2022

    Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • AK104 injection
    • +3 more
    • (no location specified)
    Apr 4, 2023

    Advanced Solid Tumors Trial in Worldwide (BMS-986360, Docetaxel, Nivolumab)

    Recruiting
    • Advanced Solid Tumors
    • Los Angeles, California
    • +15 more
    Jan 9, 2023

    Gastric Cancer Trial in Changchun (Neoadjuvant Therapy)

    Recruiting
    • Gastric Cancer
    • Neoadjuvant Therapy
    • Changchun, Jilin, China
      the First Hospital of Jilin University
    Aug 3, 2021

    Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Ipilimumab )

    Active, not recruiting
    • Renal Cell Carcinoma
    • Nivolumab
    • +2 more
    • Washington, District of Columbia
    • +77 more
    Jan 6, 2023

    Clear Cell Renal Cell Carcinoma Trial in Worldwide (Nivolumab and rHuPH20, Nivolumab)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Nivolumab and rHuPH20
    • Nivolumab
    • Chicago, Illinois
    • +104 more
    Jan 13, 2023

    Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

    Recruiting
    • Advanced Solid Tumors
    • Boston, Massachusetts
    • +5 more
    Jan 10, 2023

    Cervical Squamous Cell Carcinoma Trial in Shanghai (Tislelizumab, paclitaxel/docetaxel, cisplatin/carboplatin)

    Not yet recruiting
    • Cervical Squamous Cell Carcinoma
    • Tislelizumab, paclitaxel/docetaxel, cisplatin/carboplatin
    • Shanghai, China
      Ruijin Hospital, Shanghai JiaoTong University School of Medicine
    Aug 18, 2021

    Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Nivolumab
    • +2 more
    • Springdale, Arkansas
    • +33 more
    Nov 22, 2022

    Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • Nivolumab
    • Ipilimumab
    • Saint Louis, Missouri
    • +11 more
    Dec 15, 2022